[1]高元峰,刘昭前,李 珊,等.肿瘤中lncRNAs和circRNAs关系的研究进展[J].中国药理学通报,2018,(09):1203-1205.[doi:10.3969/j.issn.1001-1978.2018.09.005]
 GAO Yuan-feng,LIU Zhao-qian,LI Shan,et al.Study on relationship between lncRNAs and circRNAs in tumor[J].Chinese Pharmacological Bulletin,2018,(09):1203-1205.[doi:10.3969/j.issn.1001-1978.2018.09.005]





Study on relationship between lncRNAs and circRNAs in tumor
高元峰1刘昭前2李 珊1肖望重1欧阳荣1
1.湖南中医药大学第一附属医院药学部,湖南 长沙 410007; 2.中南大学湘雅医院临床药理研究所,湖南 长沙 410008
GAO Yuan-feng1 LIU Zhao-qian2 LI Shan1 XIAO Wang-zhong1 OUYANG Rong1
1.Dept of Pharmacy,the First Hospital of Hunan University of Chinese Medicine, Changsha 410007,China; 2.Dept of Clinical Pharmacology,Xiangya Hospital,Central South University,Changsha 410008,China
肿瘤 长链非编码RNA 环状RNA 非编码RNA 生物靶标 药理作用
tumor lncRNAs circRNAs ncRNA biomarkers pharmacological effects
R-05; R342.2; R73-3; R730.2
With the development of whole genome and transcriptome sequencing technologies, a growing body of long noncoding RNAs(lncRNAs)and circular RNAs(circRNAs)has been identified and is receiving increasing attention. LncRNAs and circRNAs are non-protein encoding transcripts whose functions are crucial for advancing our comprehensive understanding of biological processes in human health and diseases, specifically tumor. And there is a close relationship between circRNAs and lncRNAs in their origin and function. In this paper, we have reviewed the recent advances of lncRNAs and circRNAs in tumor by focusing on their relationships, which may help to distinguish them and identify tumor biomarkers further.


[1] Gao Y F, Wang Z B, Zhu T, et al. A critical overview of long non-coding RNA in glioma etiology 2016: an update[J]. Tumour Biol,2016,37(11):14403-13.
[2] Wang P L, Bao Y, Yee M C, et al. Circular RNA is expressed across the eukaryotic tree of life[J].PLoS One, 2014,9(6):e90859.
[3] Schneider T, Hung L H, Schreiner S, et al. CircRNA-protein complexes: IMP3 protein component defines subfamily of circRNPs[J].Sci Rep,2016,6:31313.
[4] Holdt L M, Stahringer A, Sass K, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans[J]. Nat Commun, 2016,7:12429.
[5] Suzuki H, Tsukahara T. A view of pre-mRNA splicing from RNase R resistant RNAs[J]. Int J Mol Sci, 2014,15(6):9331-42.
[6] Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency[J]. Nature,2013,495(7441):333-8.
[7] Li T, Xie J, Shen C, et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma[J]. Oncogene,2016,35(12):1575-84.
[8] Yao Y, Ma J, Xue Y, et al. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152[J]. Cancer Lett, 2015,359(1):75-86.
[9] Pastori C, Kapranov P, Penas C, et al. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation[J]. Proc Natl Acad Sci USA,2015,112(27):8326-31.
[10] Qin X, Yao J, Geng P, et al. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma[J]. Int J Clin Exp Pathol,2014,7(6):3065-72.
[11] Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus[J]. Nat Struct Mol Biol, 2015,22(3):256-64.
[12] Cao C, Sun J, Zhang D, et al. The long intergenic noncoding RNA UFC1, a target of microRNA34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells[J]. Gastroenterology,2015,148(2):415-26.
[13] Hon C C, Ramilowski J A, Harshbarger J, et al. An atlas of human long non-coding RNAs with accurate 5' ends[J]. Nature,2017,543(7644):199-204.
[14] Legnini I, Di Timoteo G, Rossi F, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis[J].Mol Cell,2017,66(1):22-37.
[15] 董宪喆,胡 园,刘 屏,等. lncRNA作为竞争性内源RNA调控胃癌进程的研究进展[J].中国药理学通报, 2016,32(9):1185-9.
[15] Dong X Z, Hu Y, Liu P, et al. The research progress of lncRNA as CeRNA in gastric cancer[J]. Chin Pharmacol Bull, 2016,32(9):1185-9.
[16] Deng N, Li L, Gao J, et al. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma[J]. Biochem Biophys Res Commun, 2018,495(1):189-96.
[17] Liu C, Pan C, Cai Y, et al. Interplay between long noncoding RNA ZEB1-AS1 and miR-200s regulates osteosarcoma cell proliferation and migration[J]. J Cell Biochem,2017,118(8):2250-60.
[18] Lv Q L, Hu L, Chen S H, et al. A long noncoding RNA ZEB1-AS1 promotes tumorigenesis and predicts poor prognosis in glioma[J]. Int J Mol Sci,2016,17(9): E1431.
[19] Ma J, Li T, Han X, et al. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma[J]. J Cancer Res Clin Oncol, 2018,144(2):205-14.
[20] Zhao B, Yang Y, Hu L B, et al. Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/ Smad signaling pathway[J]. Cancer Biomark, 2017,15:1-8.
[21] Gao Y L, Zhao Z S, Zhang M Y, et al. Long noncoding RNA PVT1 facilitates cervical cancer progression via negative regulating of miR-424[J]. Oncol Res, 2017,25(8):1391-8.
[22] Shen C J, Cheng Y M, Wang C L. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells[J]. J Drug Target, 2017,25(7):637-44.
[23] Chen J, Li Y, Zheng Q, et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer[J]. Cancer Lett, 2017,388:208-19.
[24] Xu N, Wang F, Lv M, et al. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women[J]. Biomed Pharmacother, 2015,69:221-7.
[25] Song X, Zhang N, Han P, et al. Circular RNA profile in gliomas revealed by identification tool UROBORUS[J]. Nucleic Acids Res,2016,44(9):e87.


 LIU Hong chun,DU Xiao guang,GENG Mei yu.New advances in isoformselective inhibitors of Zn2+dependent histone deacetylase[J].Chinese Pharmacological Bulletin,2010,(09):0.
 DONG Xian zhe,ZHANG Peng,BI Ming gang.Research progress on serine/threonine kinase PLK1[J].Chinese Pharmacological Bulletin,2010,(09):289.
 HU Shi lian.Melatonin in the treatment of cancer and its mechanism[J].Chinese Pharmacological Bulletin,2008,(09):0.
 LI De guan,MENG Ai min.Hematopoietic stem cell senescence[J].Chinese Pharmacological Bulletin,2008,(09):0.
 LIU Xin yan,YU Qing sheng,YU Hong e,et al.China cobra venom active factor can induce apoptosis of endothelial cells[J].Chinese Pharmacological Bulletin,2008,(09):0.
 ZHANG Zu bin,GU Zhen lun,JIANG Xiao gang.The role of miRNAs in the tumor and tumor stem cells[J].Chinese Pharmacological Bulletin,2009,(09):0.
 LI Li,LI Jing,GENG Mei yu.The role of protein kinase C in cancer and the progress of inhibitors targeting protein kinase C[J].Chinese Pharmacological Bulletin,2009,(09):0.
 LIU Ping,LI Jing.The effects of Metacycloprodigiosin on tumor metastasisassociated cell behavior in vitro[J].Chinese Pharmacological Bulletin,2010,(09):501.
 ZHANG Yan,XIAO Ting ting,SHEN Xiang chun.The advance role and pharmacological effects of metallothionein[J].Chinese Pharmacological Bulletin,2010,(09):821.


更新日期/Last Update: 2018-08-26